Skip to main content


Fig. 2 | Diabetology & Metabolic Syndrome

Fig. 2

From: Moderate- to high-intensity statins for secondary prevention in patients with type 2 diabetes mellitus on dialysis after acute myocardial infarction

Fig. 2

Cumulative probability of event rates in each study group for a primary composite outcome, b cardiovascular death, c non-fatal myocardial infarction, d non-fatal ischemic stroke. The primary composite outcome included cardiovascular death, non-fatal myocardial infarction and non-fatal ischemic stroke. The Kaplan–Meier event rate for the primary composite outcome at 8 years was 30.2% in the statin group compared with 25.2% in the non-statin group (HR, .98; 95% CI .76–1.27), but the risk of non-fatal ischemic stroke was lower in the statin group (5.9%) than that in the non-statin group (7.5%) (HR, .58; 95% CI .35–.98)

Back to article page